Abstract
Reviewing the literature, it would appear that tumor markers have often flattered to deceive. Early promise does not often seem to be borne out in extended trials. Despite apparently high specificity, very few markers are capable of assisting in a screening process.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Baum, M. (1988) Breast Cancer; The Facts. Oxford University Press, Oxford, pp. 1–6.
von Rustizky, J. (1873) Multiple myeloma. Zentralbl. Chirugie (Leipzig) 3, 102–111.
Kahler, O. (1889) Zur symptomatologie des multiplen myelomas. Wiener Med. Presse 30, 209–253.
Homburger, F. (1950) Evaluation of diagnostic tests for cancer. 1. Methodology of evaluation and review of suggested diagnostic procedures. Cancer 3, 143–172.
Bodansky, O. (1974) Reflections on biochemical aspects of human cancer. Cancer 33, 364–370.
Woodruff, M. (1990) Cellular Variation and Adaptation in Cancer. Biological Basis and Therapeutic Consequences, Oxford University Press, Oxford, pp. 1–7.
Galen, R. S. and Gambino S. R. (1975) Beyond Normality: The Predictive Value and Efficiency of Medical Diagnoses, Wiley Medical, New York.
Bayes, T. (1763) An essay toward solving a problem in the doctrine of chance. Phil. Trans. R. Soc. 53, 370–418.
Miller, A. B. (1985) Principles of screening and of the evaluation of screening programs, in Screening for Cancer, (Miller, A. B., ed.), Academic, New York, pp. 3–24.
Roulston, J. E. and Leonard, R. C. F. (1993) Serological Tumor Markers: An Introduction, Churchill Livingstone, Edinburgh, pp. 15–34.
Jacobs, I. J., Bridges, J., Stabile, I., et al. (1987) CA-125 and screening for ovarian cancer: serum levels in 1010 apparently healthy postmenopausal women. Br. J. Cancer 55, 515.
Ward B. G., Cruickshank, D. J., Tucker D. F., et al. (1987) Independent expression in serum of three tumor-associated antigens: CA125, placental alkaline phosphatase and HMFG2 in human ovarian carcinoma. Br. J. Obstet. Gynæcol. 94, 696–698.
Bormer, O. P., Paus, E., and Nustad K. (1998) Sensible use of tumor markers in routine practice. Proc. UK NEQAS Meeting 3, 140–145.
Hayes, D. F., Bast, R. C., Desch, C. E., et al. (1996) Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J.N.C.I. 88, 1456–1466.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Roulston, J.E. (2004). Assessment of Predictive Values of Tumor Markers. In: Roulston, J.E., Bartlett, J.M.S. (eds) Molecular Diagnosis of Cancer. Methods in Molecular Medicine, vol 97. Humana Press. https://doi.org/10.1385/1-59259-760-2:013
Download citation
DOI: https://doi.org/10.1385/1-59259-760-2:013
Publisher Name: Humana Press
Print ISBN: 978-1-58829-160-8
Online ISBN: 978-1-59259-760-4
eBook Packages: Springer Protocols